These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 21474342)

  • 1. Successful treatment of childhood prolonged refractory status epilepticus with lacosamide.
    Shiloh-Malawsky Y; Fan Z; Greenwood R; Tennison M
    Seizure; 2011 Sep; 20(7):586-8. PubMed ID: 21474342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacosamide for the treatment of refractory status epilepticus.
    Fernandez EM; Franck AJ
    Ann Pharmacother; 2011 Nov; 45(11):1445-9. PubMed ID: 22010001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam.
    Chen LL; Haneef Z; Dorsch A; Keselman I; Stern JM
    Seizure; 2011 Apr; 20(3):263-5. PubMed ID: 21109468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C; Resch R; Hofer T; Eggers C
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study.
    Poddar K; Sharma R; Ng YT
    Pediatr Neurol; 2016 Aug; 61():83-6. PubMed ID: 27241232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Seizure; 2011 Sep; 20(7):529-32. PubMed ID: 21489827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.
    Hawkes MA; Fernández Suárez M; Ugarnes G; D'Giano C
    Clin Neuropharmacol; 2013; 36(4):138-40. PubMed ID: 23860347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment: lacosamide for the treatment of refractory status epilepticus.
    Trinka E; Höfler J; Tilz C; Kellinghaus C
    Ann Pharmacother; 2012 May; 46(5):765-6; authors reply 766-7. PubMed ID: 22570435
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of lacosamide in children and adolescents with drug-resistant epilepsy and refractory status epilepticus: A systematic review.
    Ortiz de la Rosa JS; Ladino LD; Rodríguez PJ; Rueda MC; Polanía JP; Castañeda AC
    Seizure; 2018 Mar; 56():34-40. PubMed ID: 29428899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous lacosamide--an effective add-on treatment of refractory status epilepticus.
    Albers JM; Möddel G; Dittrich R; Steidl C; Suntrup S; Ringelstein EB; Dziewas R
    Seizure; 2011 Jun; 20(5):428-30. PubMed ID: 21354831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of refractory absence status epilepticus with lacosamide.
    Sodemann U; Møller HS; Blaabjerg M; Beier CP
    J Neurol; 2014 Oct; 261(10):2025-7. PubMed ID: 25201223
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus.
    Koubeissi MZ; Mayor CL; Estephan B; Rashid S; Azar NJ
    Acta Neurol Scand; 2011 Feb; 123(2):142-6. PubMed ID: 21198444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of refractory tonic status epilepticus with intravenous lacosamide.
    Jain V; Harvey AS
    Epilepsia; 2012 Apr; 53(4):761-2. PubMed ID: 22462573
    [No Abstract]   [Full Text] [Related]  

  • 14. Lacosamide as a new treatment option in status epilepticus.
    Höfler J; Trinka E
    Epilepsia; 2013 Mar; 54(3):393-404. PubMed ID: 23293881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
    Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
    Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
    Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
    Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacosamide in status epilepticus: Update on the TRENdS study.
    Husain AM
    Epilepsy Behav; 2015 Aug; 49():337-9. PubMed ID: 26152818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of lacosamide on seizures and myoclonus in a patient with epilepsia partialis continua.
    Spalletti M; Comanducci A; Vagaggini A; Bucciardini L; Grippo A; Amantini A
    Epileptic Disord; 2013 Jun; 15(2):193-6. PubMed ID: 23761109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lacosamide in absence status epilepticus: effective or ineffective?
    d'Orsi G; Pascarella MG; Martino T; Specchio LM
    Seizure; 2015 Feb; 25():32. PubMed ID: 25645632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.